Faculty profile

Bishal Gyawali

Back to faculty

ProfessorDepartment of OncologyQueen's University

Bishal Gyawali

Professor

Department of Oncology

Queen's University

Kingston, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
109 publications in the last five years, latest in 2026.
Senior (last) author on 39 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

172

Publications

1,769

Citations

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Queen's University profile.

Clinical research and improved regulatory practices Access to affordable cancer treatments worldwide

Latest papers

Decentralizing Post-Treatment Follow-Up for Cervical Cancer in Rwanda: Perspectives of Survivors and Clinicians
JCO Global Oncology · 2026
(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.
Journal of the National Cancer Institute · 2026
Territorial inequality in oncology clinical trial participation and its ecological association with cancer mortality in Spain.
Journal of cancer policy · 2026

All 172 publications

From the 150 most recent of 172 publications.

Decentralizing Post-Treatment Follow-Up for Cervical Cancer in Rwanda: Perspectives of Survivors and Clinicians

Fidel Rubagumya, Vincent Kwizera, Isabelle Mutetiwabo, Adebola Alade Adedimeji, Mary Dickinson Chamberlin, Nina S.N. Ngowi, Bishal Gyawali, Christine M. Gunn, Lidia Schapira, Léon Mutesa, Laetitia Nyirazinyoye

JCO Global Oncology2026Open Access

DOI: 10.1200/go-26-00131 PMID: 42753200

(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.

Valiente CM, Mittal A, Tu D, Amir E, Pater J, Dancey J, Gyawali B, Booth CM, Wilson BE

Journal of the National Cancer Institute2026Open Access

DOI: 10.1093/jnci/djag133 PMID: 42714223

Territorial inequality in oncology clinical trial participation and its ecological association with cancer mortality in Spain.

Lázaro-Sánchez AD, Dastgerdi MF, Rodríguez-Lescure A, Romero JLA, Moya-Martínez A, Quesada AIM, García-Foncillas J, Fernández-Molina B, de Luna Aguilar A, Gyawali B, Benítez-Fuentes JD

Journal of cancer policy2026

DOI: 10.1016/j.jcpo.2026.100808 PMID: 42716430

De-escalation trials do not always need to be noninferiority: a case for superiority design de-escalation trials in oncology.

Gyawali B

Journal of the National Cancer Institute2026First author

DOI: 10.1093/jnci/djaf322 PMID: 41206129

RECITE this mantra in chemotherapy-induced thrombocytopenia: treat patients, not platelets.

Benitez-Fuentes JD, Teuwen LA, Gyawali B

Nature reviews. Clinical oncology2026Senior author

DOI: 10.1038/s41571-026-01170-x PMID: 42265273

Cancer Medicine Approvals in the US.

Shkabari B, Vorko NI, Geerlinks WM, Purh E, Diana-Gonsalves CM, Sutaria S, Gyawali B

JAMA2026Senior author

DOI: 10.1001/jama.2026.12089 PMID: 42530909

Common sense oncology values to action: a patient-led framework for randomized clinical trial design.

Tregear ML, Verduzco-Aguirre HC, Shkabari B, Koven R, Scowcroft H, Venkatash V, Brundage MD, Chidebe RCW, Eisenhauer EA, Gyawali B, Sirohi B, Booth CM, Jackson CGCA

Journal of the National Cancer Institute2026

DOI: 10.1093/jnci/djag092 PMID: 41941752

The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis.

Menon TP, Selvasingh J, Jella TK, Pramesh CS, Gunasekera S, Radhakrishnan V, Prasad M, Goel S, Modak S, Wolden SL, Jackson CB, Gyawali B, Dee EC

The Lancet regional health. Southeast Asia2026

DOI: 10.1016/j.lansea.2026.100815 PMID: 42519114

Early termination of clinical trials enrolling patients with breast cancer: Reasons, determinants, and temporal patterns.

Iannantuono GM, Daniele G, Mastrantoni L, Giannarelli D, Trapani D, Gyawali B, Sganga S, Giudice E, Riondino S, Krasniqi E, Capici S, Pepe FF, Torrisi R, Spinazzola A, Bassolino A, Meacci A, Yazdanpanahardakani K, Padula L, Rosenfeld R, Carbognin L, Lorusso D, Curigliano G, Gulley JL, Fabi A, Bria E, Roselli M, Floudas CS, Cazzaniga ME

Breast (Edinburgh, Scotland)2026

DOI: 10.1016/j.breast.2026.104931 PMID: 42772169

Global determinants of cervical cancer outcomes: a health systems analysis.

Go AE, Feliciano EJG, Martinez J, Ho FDV, Wu JF, Willmann J, Lapen K, Hugo H, Jeong Y, Singh A, Haylock AB, Shah N, Robredo JPG, Eala MAB, Patel RK, Chen J, Cabaero MLL, Tawfiles D, Venkateswaran S, Tan AKNG, Gyawali B, Moraes FY, Iyengar P, Lee NY, Mango VL, Taunk NK, Magsanoc-Alikpala MJK, Kingham TP, Dee EC

BMJ oncology2026

DOI: 10.1136/bmjonc-2025-000975 PMID: 41584365

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Bishal Gyawali

Research

Latest papers

Decentralizing Post-Treatment Follow-Up for Cervical Cancer in Rwanda: Perspectives of Survivors and Clinicians

(Neo)adjuvant approvals for solid tumors by the US Food and Drug Administration 2010-2023.

Territorial inequality in oncology clinical trial participation and its ecological association with cancer mortality in Spain.

De-escalation trials do not always need to be noninferiority: a case for superiority design de-escalation trials in oncology.

RECITE this mantra in chemotherapy-induced thrombocytopenia: treat patients, not platelets.

Cancer Medicine Approvals in the US.

Common sense oncology values to action: a patient-led framework for randomized clinical trial design.

The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis.

Early termination of clinical trials enrolling patients with breast cancer: Reasons, determinants, and temporal patterns.

Global determinants of cervical cancer outcomes: a health systems analysis.

Frequent collaborators

Nazik Hammad

Kristin Wright

Fidel Rubagumya

Ophira Ginsburg

Gregory Pond

Christopher Booth

Brooke Wilson

Matthew McInnes

Kelvin Chan

Matt McInnes

Timothy Hanna

Michael Brundage

Matthew Cheung

Siddhartha Srivastava

Avram Denburg

Sunil Patel

Rajesh Dikshit

Eitan Amir

Philippe Bedard

Dongsheng Tu

Peter Sabatini

Shaila Merchant

Wiley Chung

Sulaiman Nanji

Janet Dancey

Ross Upshur

Sergio Sismondo